Syncom Formulations (India) Ltd Share Price

Overview

Syncom Formulations (India) Ltd share price is currently ₹16.86, up by ₹0.97 (6.1%) from its previous closing price of ₹15.89. The share price has gained 30.7% over the past month and declined -7.62% over the past year. The stock's 52-week low and high are ₹9.85 and ₹18.64, respectively. Syncom Formulations (India) Ltd has a market capitalisation of ₹ 1,520.00 Cr. The share price was last updated on 24 Aug 2026, 03:57 PM IST.

Syncom Formulations (India) Ltd

SYNCOMF

₹0.00

₹0.97

6.10%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:57:32 pm IST

Market Data

Open Price

₹17.04

Prev. Close

₹15.89

₹16.75

Day Low

₹17.18

Day High

₹9.85

52 Week Low

₹18.64

52 Week High

HealthcarePharmaceuticals & Drugs

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

18.53

Sector PE

42.03

PB Ratio

4.63

Sector PB

5.82

EPS

0.91

Dividend Yield

0.00

Today's Volume

16.466 M

5 Day Avg. Volume

6.733 M

PEG Ratio

0.19

Market Cap.

₹ 1,520.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 10% at ₹0.1/Share	23-Sep-2026	23-Sep-2026

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Motilal Oswal BSE Healthcare ETF	12.35 k	12.62 k (2.17%)
Bandhan BSE Healthcare Index Fund - Regular Plan - Growth	6.32 k	6.77 k (7.1%)

About Syncom Formulations (India) Ltd 👋

Syncom Formulations (India) Limited is an India-based company that is engaged in the pharmaceutical business. The Company is engaged in the development, manufacturing & sale of pharmaceutical products and services& trading of commodities and renting of properties. The Company manufactures and markets more than 200 pharmaceutical formulation products in various dosage forms, like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections and Dry Vial injections, Dry Syrups, Ointments and Inhalers. The Company's domestic division product categories include Cratus Life Care, Cratus Evolve and Cratus Right Nutrition. Its products include Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Ciprofloxacin Tablets USP 750 mg, Cefazolin For Injection USP 1 gm, Cefotaxime For Injection USP 1 gm, Ceftriaxone for Injection USP 500 mg, Albendazole Oral Suspension USP 100mg, Cetirizine Oral Solution BP, Clotrimazole Cream USP, Compound Benzoic Acid Ointment BP, and others.